ABBOTT LABORATORIES

ABT stock holders 13F

6 superinvestors reported owning ABT (Common Stock) according to the gurus' 2023 Q4 reports.

Top 5 gurus who own (ABT) ABBOTT LABORATORIES

The top 5 super investors (holders) owning ABT (by the percentage (%) of portfolio) are David M. Polen - Polen Capital Management (3.58%), C.T. Fitzpatrick - Vulcan Value Partners (1.07%), Andrew R. Adams - Mairs & Power Growth Fund (0.90%), Paul Lountzis - Lountzis Asset Management (0.46%) and Eric H. Schoenstein - Jensen Investment Management (0.09%) as of their 2023 Q4 reports.

To check the latest activities of the top ABT shareholders between value investors, please click on the "Activity" tab.

To see the historical data of ABT's holders please click on the "2023 Q4" dropdown menu and select the date.

# of holders: 6
Period: 2023 Q4
Type: Common Stock
Andrew R. Adams
0.90%
411,304
$110.07
$45,272,231
C.T. Fitzpatrick
1.07%
665,088
$110.06
$73,198,000
-8.41% (-61,077)
-0.10%
David M. Polen
3.58%
13,488,308
$110.08
$1,484,818,780
+0.06% (+7,572)
+0.00%
Eric H. Schoenstein
0.09%
103,403
$110.07
$11,381,568
Paul Lountzis
0.46%
7,625
$110.07
$839,284
Thomas Russo
0.01%
10,855
$110.07
$1,194,848
Current price: $117.76 6.99% AVG reported hold price*: $110.07

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.